Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 2, 2017

View Archived Issues

Discovery of a novel orally bioavailable HSF1 pathway inhibitor, CCT-251236

miRNAs identified as regulators of intestinal epithelial barrier function in IBS-D

Allergy Therapeutics reports preclinical findings on Polyvac Peanut

Pfizer descirbes new PI3Kalpha inhibitors

The University of Texas, Loyola University Chicago identify novel dimetalloenzymes inhibitors

Galapagos and AbbVie present CFTR channel correctors

Roche divulges novel mGlu4 positive allosteric modulators

Researchers from FAU and Sancilio collaborate to develop treatment for retinitis pigmentosa

Takeda presents new histone deacetylase inhibitors

Oncology Venture Sweden announces status update on its oncology pipeline

InFlectis BioScience forms strategic partnership in ophthalmology

Pfizer profiles pipeline progress of fourth quarter 2016

Alzamend Neuro licenses USF immunotherapeutic treatment for Alzheimer's

EA Pharma submits NDA in Japan for elobixibat

FDA grants rare pediatric disease designation to NS-065

EMA grants BioMarin's BMN-270 for hemophilia A access to PRIME initiative

Allergan completes acquisition of LifeCell

Novo Nordisk and University of Oxford collaborate on discovery of innovative therapies

Meridian Laboratories and Apobiologix sign definitive agreement for docetaxel injection

FDA grants hydroxypioglitazone orphan drug status for the treatment of X-linked adrenoleukodystrophy

Vixotrigine given FDA orphan drug designation for erythromelalgia

New B-SMART project to develop RNA-based therapy for neurodegenerative diseases

miRNAs as biomarkers of response to stem cell therapy in rheumatoid arthritis

Chugai Pharmaceutical highlights progress of fourth quarter 2016

NCI grant supports Personal Genome Diagnostics' development of MutatorDETECT

MeiraGTx receives grant for gene therapy for ALS

Targovax reports survival data from first cohort of phase I/II study of TG-01 in pancreatic cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...